glp 1 agonist new drug List of approved and pending GLP-1 medications Retatrutide for weight loss: Study

Among the most promising treatments we provide are GLP-1 medications, a specialized class of medications known as glucagon-like peptide-1 receptor agonists

The most common ones include: Nausea Vomiting Diarrhea or constipation Stomach pain Fatigue Most side effects are mild and improve over time

A comprehensive meta-analysis of eight GLP-1 RA CVOTs revealed several critical findings: 14% reduction in major adverse cardiovascular events (MACE: cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke) [3] 13% reduction in cardiovascular death [3] 10% reduction in all-cause mortality [3] 11% reduction in hospitalization for heart failure [3] Post-hoc analyzes from LEADER and SUSTAIN-6 revealed that cardiovascular benefits extended across the spectrum of body mass index categories, indicating efficacy regardless of baseline weight [2]

Along with the price and rebound weight gain, these injectables are a gamble with your long-term health and weight loss

Retarutide is a subcutaneously injected tri-agonist (GLP-1/GIP/glucagon receptor) that demonstrated unprecedented levels of weight loss in a relatively short period of time